Alkahest, Inc.   Report issue

For profit Phase 2
Founded: San Carlos CA United States (2014)
Status: Acquired by Grifols (2020)

Organization Overview

First Clinical Trial
2014
NCT02256306
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alkahest, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Cognitive Dysfunction (Phase 2)

Macular Degeneration (Phase 2)

Parkinson Disease (Phase 2)

Pemphigoid, Bullous (Phase 2)

Wet Macular Degeneration (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 11
  • # of Trial APIs: 6